All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 159 of 206 pages ‹ First < 157 158 159 160 161 > Last ›
HSL10247
Mongin Bulewski C.
Drug Discovery Technology 2002: Keynote lectures: 4-9 August 2002, Boston, MA, USA
IDrugs 2002;5:(9):900-901
HSL10369
Dexmethylphenidate - Novartis/Celgene: Focalin, D-MPH, D-methylphenidate hydrochloride, D-methylphenidate, dexmethylphenidate, dexmethylphenidate hydrochloride
Drugs in R and D 2002;3:(4):279-282
HSL10433
Selegiline: a second look.
Six years later: too risky in Parkinson's disease 2002;11:(60):108-111
HSL10436
Iloprost - A small benefit in severe Raynaud's phenomenon
Prescrire International 2002;11:(58):63
HSL10474
Frasca V, Paladini L, Balestrieri A.
Prescription information leaflets: An expression of pharmaceutical care
Giornale Italiano di Farmacia Clinica 2002;16:(4):207-209
HSL10486
Ou YJ.
A survey of pharmacists' recommendation in a unit dose drug distribution system
Chinese Pharmaceutical Journal 2002;54:(6):449-455
HSL10526
Oreskovic S.
Pharmacoeconomics - Concepts, methods and controverses
Medicus 2002;11:(1):27-36
HSL10528
De Joncheere K, Rietveld AH, Huttin C.
Experiences with generics
International Journal of Risk and Safety in Medicine 2002;15:(1-2):101-109
HSL10538
McCloskey A.
The high price of prescription drugs and its impact on the elderly.
Care Manag J 2002 Spr;3:(3):143-53
HSL10539
Kellogg FR.
Editorial
Care Management Journals 2002;3:(3):112
HSL10540
Brown K.
The medication merry-go-round
Science 2002;299:(5613):1646-1649
HSL10548
Hilli R, Groop T.
Generic Substitution - The proposed procedure for the presciption of pharmaceuticals in Finland
EPC--European Pharmaceutical Contractor 2002;101-103
HSL10549
Schulman D, Wallis D, Hunsperger H.
Prescription drug Co-Promotion: 21st century dealmaking
EPC European Pharmaceutical Contractor 2002;26-28
HSL10550
Coppin B.
A call to regulate the online sale of prescription drugs
EPC European Pharmaceutical Contractor 2002;18-20
HSL10624
Tacco F, Taggiasco N, Broissand C.
Quality assurance in hospital pharmacies: Dispensation of thalidomide
Pharmacien Hospitalier 2002;37:(151):219-226
HSL10627
Tam J.
Seeing red over drug price comparisons [1]
Canadian Pharmaceutical Journal 2002-2003;135:(10):
HSL10632
Breggin PR.
Fluvoxamine as a cause of stimulation, mania, and aggression: A critical analysis of the FDA-approved label
Ethical Human Sciences and Services 2002;4:(3):211-227
HSL10637
Drachenberg KJ, Proll S, Urban E, Woroniecki SR.
Short-term immunotherapy using an allergy vaccine adjuvanted with monophosphoryl lipid A: A post-marketing surveillance study
International Review of Allergology and Clinical Immunology. 2002;8:(4):219-223
HSL10642
Spinosi P, Ciampoli R, Turchetti M.
Did any change occurr in the NSAIDs prescription following the marketing of selective COX-2 inhibitors?
Giornale Italiano di Farmacia Clinica 2002;16:(3):138-142
HSL10643
Horn SD.
Unintended consequences of restricting drug access
Drug Benefit Trends 2002;14:
HSL10650
Krymchantowski AV, Irikura S, Barbosa JS, Lysia R, Tavares C, Rocha N, Moreira PF.
Headache medications in drugstores of Brazil. Profiles of orientation, recommendation and sale carried out by unskilled employees with inadequate approaches
Revista Brasileira de Medicina 2002;59:(10-11):705-710
HSL10651
Mason RG, Donaldson D.
Lessons to be learned: A case study approach Chinese herbal nephropathy and urothelial malignancy
Journal of The Royal Society for the Promotion of Health 2002;122:(4):266-267
HSL10654
Gallagher RM.
Methadone and spinal stimulation: Old wine in new bottles
Pain Medicine 2002;3:(4):293
http://www.blackwell-synergy.com/rd.asp?code=PME&vol=3&page=293&goto=abstract
HSL10655
Kanemori DS.
Future packaging image
American Pharmaceutical Outsourcing 2002;3:(4):18-22
HSL10657
Something for everyone - Patients, health care professionals and industry
Pharmaceutical Journal 2002;269:(7228):861
HSL10659
Noferi JF, Arling ER, Dillon RL.
Counterfeit drugs: A new paradigm for security
American Pharmaceutical Review 2002;5:(4):37
HSL10660
Dwyer P.
Drug therapy and legal liability
Australian Journal of Forensic Sciences 2002;34:(2):45-46
HSL10661
Striking-off for Viagra sale to journalist
Pharmaceutical Journal 2002;269:(7227):829
HSL10664
Zeidler H, Kaltwasser JP, Leonard JP, Kohlmann T, Sigmund R, Degner F, Hettich M.
Prescription and tolerability of meloxicam in day-to-day practice: Postmarketing observational cohort study of 13,307 patients in germany
Journal of Clinical Rheumatology 2002;8:(6):305-315
HSL10665
Patient packs need attention too
Pharmaceutical Journal 2002;269:(7226):766
HSL10666
Wechsler J.
Major changes ahead for FDA
Pharmaceutical Technology Europe 2002;14:(11):17-20
HSL10667
Albedo A.
Battle commences on the future of EU drugs
Pharmaceutical Technology Europe 2002;14:(11):11-13
HSL10670
Sodium oxybate/GHB approved for cataplexy
WHO Drug Information 2002;16:(2):136
HSL10671
Alosetron hydrochloride: Restricted marketing
WHO Drug Information 2002;16:(2):135
HSL10672
MacKay DKJ.
Prescribing cascade for non-food-producing species, and changes relating to cushing's disease [1]
Veterinary Record 2002;151:(21):643
HSL10673
Pet medicines 'resource pack' for pharmacists
Veterinary Record 2002;151:(21):620
HSL10674
Abraham J.
Making regulation responsive to commercial interests: Streamlining drug industry watchdogs
British Medical Journal 2002;325:(7373):1164-1167
HSL10675
Barnes J.
Herbal therapeutics: (7) Colds
Pharmaceutical Journal 2002;269:(7224):716
HSL10676
OTC availability shout not be endorsed yet [1]
Pharmaceutical Journal 2002;269:(7224):711
HSL10677
Cost and compliance affect statin use
Pharmaceutical Journal 2002;269:(7224):706
HSL10678
Dispensing glucosamine
Pharmaceutical Journal 2002;269:(7224):705
HSL10821
Curth L.
The commercialisation of medicine in the popular press: English almanacs 1640-1700.
Seventeenth Century 2002;17:(1):48-69
HSL11900
Goldman CR, Cutler DL.
Pharmaceutical industry support of psychiatric research and education: Ethical issues and proposed remedies.
Backlar P, Cutler DL. Ethics in community mental health care: Commonplace concerns. New York: Kluwer Academic/Plenum Publishers 2002
HSL12352
Quintaneiro T.
[The Brazilian pharmaceutical market and the North American war effort].
Estud Hist. 2002;(29):141-64
HSL13290
Lexchin J, Mintzes B.
Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No
Journal of Public Policy and Marketing 2002;21:(2):194-201
http://web.archive.org/web/20080511145449/http://www.marketingpower.com/content18627.php
HSL13304
Pecotich A, Ward SP, Song Y.
Just a Spoonful of Sugar: Patent Brand Name Effects on the Antidepressant Prescription Habits of Psychiatrists and General Practitioners
Cadeaux J, Pecotich A, Eds . Macromarketing in the Asia Pacific Century: The Proceedings of the 27th Annual Macromarketing Conference Sydney: University of New South Wales 2002
HSL13370
Schubert F.
Health technology assessment. The pharmaceutical industry perspective
Int J Technol Assess Health Care. 2002 Spring;18:(2):184-91
http://www.ncbi.nlm.nih.gov/pubmed/12053418
HSL16342
Healy D
The Creation of Psychopharmacology. Cambridge: Harvard University Press 2002
http://books.google.com.au/books?id=6O2rPJnyhj0C&dq=Healy,+David.+The+Creation+of+Psychopharmacology.&printsec=frontcover&source=bn&hl=en&ei=MJyYSti2EJjQ6gOa4ODnBA&sa=X&oi=book_result&ct=result&resnum=4#v=onepage&q=&f=false
HSL17904
Ed.
Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
BMJ 2002;324:(7349):1287
http://www.bmj.com/cgi/content/extract/324/7349/1287
HSL17985
Mavroforou A, Michalodimitrakis E
Legal aspects related to marketing and use of medicinal products in Greece.
Med Law. 2002;21:(1):1-10
http://www.ncbi.nlm.nih.gov/pubmed/12017435
HSL19052
Schwartz LM, Woloshin S.
Marketing medicine to the public: a reader's guide.
JAMA 2002 13;287:(6):774-5
http://jama.ama-assn.org/content/287/6/774.long
HSL19392
Azoulay P
Do pharmaceutical sales respond to scientific evidence?
J Econ Manage Str 2002;11:551–594
http://ideas.repec.org/a/bla/jemstr/v11y2002i4p551-594.html
HSL2239
Schwab D.
Patent protection is at forefront of the pharmaceutical industry's concerns for the coming years
STAR-LEDGER 2001 Dec 30
HSL2240
Kolata G.
Questions Grow Over Usefulness of Some Routine Cancer Tests
New York Times 2001 Dec 30
http://www.nytimes.com/2001/12/30/us/questions-grow-over-usefulness-of-some-routine-cancer-tests.html?pagewanted=1
HSL2238
Freudenheim M, Petersen M.
The Drug-Price Express Runs Into a Wall
The New York Times 2001 Dec 23
http://www.nytimes.com/2001/12/23/business/the-drug-price-express-runs-into-a-wall.html?pagewanted=1
HSL17994
Somerset M, Weiss M, Fahey T.
Dramaturgical study of meetings between general practitioners and representatives of pharmaceutical companies; Commentary: dramaturgical model gives valuable insight.
BMJ 2001 Dec 22-29;323:(7327):1481-4
http://www.bmj.com/cgi/content/full/323/7327/1481?view=long&pmid=11751364
HSL2236
Who Medicines Expert Calls For New Rules Against Commercial Bias In Medical Research
J Adv Nurs. 2001 Dec 17
http://www.ncbi.nlm.nih.gov/pubmed/12108409
HSL2237
Firn D.
Patent disputes and litigation take shine off 2001
Financial Times 2001 Dec 17
HSL17992
Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS.
Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey.
JAMA 2001 Dec 12;286:(22):2823-9
http://jama.ama-assn.org/cgi/content/full/286/22/2823
HSL17993
Avorn J.
Improving drug use in elderly patients: getting to the next level.
JAMA 2001 Dec 12;286:(22):2866-8
http://jama.ama-assn.org/cgi/content/full/286/22/2866
HSL17373
Carey J, Barrett A, Weintraub A
Drug Prices: What's Fair?
Business Week 2001 Dec 10
http://www.businessweek.com/magazine/content/01_50/b3761001.htm
HSL2234
Protest against drug company manipulation of doctors' choice of drugs
2001 Dec 8
HSL17375
Brown D, Landy J
Report on PNHP-NY Protest Against Drug Company Manipulation of Doctors’ Choice of Drugs
Physicians for a National Health Program New York Chapter 2001 Dec 8
HSL2232
Japsen B.
Doctors ask to keep prescribing secret AMA data selling reaps $20 million
Chicago Tribune 2001 Dec 4
HSL2233
Steinman M.
New Study Shows Low-Income, Minority Seniors Restrict Use of Prescription Drugs
2001 Dec 4
HSL2230
Morse L.
Scenario: How a resident can spell relief from "ethical heartburn"
AMNews 2001 Dec 3
HSL2231
Greene J.
Medical groups tout AMA drug industry gift campaign
AMNews 2001 Dec 3
HSL3684
US FDA.
Direct-to-you: DTC ads that make sense. [Consumer Talk Paper]
Rockville, Md.: US FDA. 2001 Dec 3
http://www.fda.gov/cder/about/whatwedo/testtube-11.pdf
HSL33
Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001 Dec;76:(12):1271-1277
http://www.academicmedicine.org/cgi/content/full/76/12/1271
HSL2241
Quick J.
Maintaining the integrity of the clinical evidence base
World Health Organisation Bulletin 2001 Dec;
HSL2259
Weber LJ, Wayland MT, Holton B.
Health care professionals and industry: reducing conflicts of interest and established best practices.
Arch Phys Med Rehabil 2001 Dec;82:(12):
http://linkinghub.elsevier.com/retrieve/pii/aapmr082b0s20
HSL2375
Newsweek 'adverzine'?
Consumers Union 2001 Dec;63
HSL2376
Anonymous .
DTC advertising: Mixed messages
CMJ 2001 Dec;133:(10):20
HSL5380
Steinman MA, Sands LP, Covinsky KE.
Self-restriction of medications due to cost in seniors without prescription coverage.
J Gen Intern Med 2001 Dec;16:(12):793-9
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2001.10412.x
HSL7828
Lima HA.
Reimbursement issues for biotherapies: trends and future issues
ASHP Midyear Clinical Meeting 2001 Dec;36:
HSL7829
Mangino MH, Ptachcinski RJ, Hrinya M, Stdenis J.
Five year experience with a medication acquisition cost reduction program for the indigent
ASHP Midyear Clinical Meeting 2001 Dec;36:
HSL7830
Kostek NE.
Effective use of managed care contracting to improve inpatient revenues in an acute care setting
ASHP Midyear Clinical Meeting 2001 Dec;36:
HSL7832
Haberman DJ, Clifton GD.
Development of an automated service to support access to pharmaceutical companies' patient assistance program
ASHP Midyear Clinical Meeting 2001 Dec;36:
HSL7833
Shah ND.
Use of trend data on medication use volume in the forecasting process
ASHP Midyear Clinical Meeting 2001 Dec;36:
HSL10462
Zanamivir: a second look - Still no tangible impact on influenza.
Prescrire Int 2001 Dec;10:(56):175-7
HSL17991
Meade-D'Alisera P, Merriweather T, Wentland M.
Impact of commercial marketing on patient demand.
Urol Nurs 2001 Dec;21:(6):406-7,
http://www.ncbi.nlm.nih.gov/pubmed/11998507
HSL2229
Survey Finds DTC Ads Good for Communicating Basic Information
Reuters Health 2001 Nov 29
HSL2228
De Bourbon L.
Poll: Many Don't Fill Prescriptions
AP Business Writer 2001 Nov 28
HSL2226
The Remicade Letters
CBS News 2001 Nov 27
http://www.cbc.ca/disclosure/archives/0111_letters/story.html
HSL2227
Marketing Medication: Can a Good Deal Mean Bad Medicine?
ABC News 2001 Nov 27
http://web.archive.org/web/20040917075843/http://abcnews.go.com/sections/GMA/GoodMorningAmerica/GMA011127Free_prozac.html
HSL20394
Sibbald B
In Russia, medical profession plods toward 21st century
CMAJ 2001 Nov 27;165:(11):1521
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC81679/
HSL2223
A complaint about drug company advertising
BMJ 2001 Nov 24
HSL2224
Burton R, Burton B
Selling drugs -- with a little help from a journalist
BMJ 2001 Nov 24
HSL2225
Sweet M
Sponsored journalism award shocks Australian media
BMJ 2001 Nov 24
HSL17999
Carvel D
A complaint about drug company advertising.
BMJ 2001 Nov 24;323:(7323):1259
http://www.bmj.com/cgi/content/citation/323/7323/1259
HSL12934
Ashmore R, Carver N.
Mental health nursing. The pharmaceutical industry and mental health nursing.
British Journal of Nursing 2001 Nov 22;10:(21):1396-402
http://www.britishjournalofnursing.com/
HSL2218
Reporting of 6 Month vs 12 Month Data in a Clinical Trial of Celecoxib
JAMA 2001 Nov 21
http://jama.ama-assn.org/cgi/content/extract/286/19/2398
HSL2220
Petersen M.
Increased Spending on Drugs Is Linked to More Advertising
New York Times 2001 Nov 21
http://www.nytimes.com/2001/11/21/business/21DRUG.html?pagewanted=1
HSL2221
Silverman E.
Consumers buy what drug firms pitch
Star-Ledger 2001 Nov 21
HSL2222
Bristol-Myers Squibb Effort to Extend Glucophage Patent Galvanizes Congress and Divides Drug Industry
Kaisernetwork.org 2001 Nov 21
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=8166
HSL2260
Wright JM, Perry TL, Bassett KL, Chambers GK.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
JAMA 2001 Nov 21;286:(19):2398-400
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11712925&query_hl=7
HSL2509
Wright JL, Perry TL, Bassett KL, Chambers GK.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [2nd of 3 letters]
JAMA 2001 Nov 21;286:(19):2398-9
http://web.archive.org/web/20021019090659/http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html
HSL2560
Hrachovec J, Mora M.
Reporting of 6-month vs 12-moth data in a clinical trial of celecoxib [1st of 3 letters]
JAMA 2001 Nov 21;286:(19):2398
http://web.archive.org/web/20100104034241/http://jama.ama-assn.org/
HSL2219
Guerrera F, Jennen B.
Brussels to set record fines for vitamin cartel
Financial times 2001 Nov 20
HSL2214
Wolfe S.
The AMA Does It Again
2001 Nov 19
http://www.citizen.org/publications/release.cfm?ID=7134
Page 159 of 206 pages ‹ First < 157 158 159 160 161 > Last ›
